So many of these adult stem cell success stories come to me now, that I am unable to post them all here at SHS. Two recent examples: A new adult stem cell therapy is successfully restoring vision to people with chemical injuries and a genetic defect that causes impaired vision. From the story:
Using stem cells from tissue donors, surgeons grew the cells in the laboratory before transplanting them onto the patients’ eyes.
Dr Julie Daniels, who is leading the research team, will present the results at a conference on regenerative medicine being held in Welwyn Garden City, Hertfordshire, today. She said: “Before the surgery the patients were barely able to recognise when someone was waving a hand in front of their face but we have restored their vision to the point they can read three to four lines down the eye chart.”
Nineteen patients have now received the treatment, known as limbal stem cell therapy, at Moorfields Eye Hospital.
Meanwhile, scientists have discovered a molecule that may one day lead to important regenerative techniques with a patient’s own nerve stem cells. From the story:
Inspired by a chance discovery during another experiment, researchers at UT Southwestern Medical Center have created a small molecule that stimulates nerve stem cells to begin maturing into nerve cells in culture.
This finding might someday allow a person’s own nerve stem cells to be grown outside the body, stimulated into maturity, and then re-implanted as working nerve cells to treat various diseases, the researchers said. “This provides a critical starting point for neuro-regenerative medicine and brain cancer chemotherapy,” said Dr. Jenny Hsieh, assistant professor of molecular biology and senior author of the paper, which appears online today and in the June 17 issue of Nature Chemical Biology
This is the opposite of no news being good news. With adult stem cell research, too much news to fit manageably within a blog format is very good news, indeed.
Dear Reader,
Can I be direct with you?
War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.
First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.
But we can’t do it without readers like you.
Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.
Your gift anchors readers in the permanent things.
Make your Fall Campaign gift now using the button below.
If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
